1999 perspective in drug industry: Bioequivalency test standards.

The KFDA announced the revised provisions concerning the new standards for bioequivalent test containing the extension of qualified institutes of test to all medical institutes and the increased number of test examiners from 3 to 4 on Dec. 22.

The bioequivalent test will be very important for drug industries since under the medical and pharmacy separation system the branded drug prescribed b...